Endeavor

Moffitt Trial Reports Higher Survival for HER2-Positive Breast Cancer Patients With Leptomeningeal Metastases

The phase 2 trial shows patients treated with radiation therapy followed by two antibodies delivered intrathecally had a median overall survival of 36 months

New Initiative Hopes To Bring Clinical Trials to Breast Cancer Patients in Barbados

Women on the Caribbean island are more likely to be diagnosed with an aggressive form of the disease

Thinking Outside the Box With Adaptive Breast Cancer Clinical Trial

Adaptive clinical trial gives earlier stage breast cancer patient chance to pioneer next generation of treatments 

Cell Therapy Changed Cancer Care. Now Researchers Want to Make It Work Better

Moffitt brought together experts from across the country to explore ways to make cell therapies more durable and effective for more patients

Metastatic Breast Cancer Patient Continues To Watch Family Grow Thanks to Clinical Trial

Tamara Holt was 42 with two young sons when she was diagnosed with triple-negative breast cancer

Moffitt Trial Tests Immunotherapy Without Chemotherapy for Early Stage Breast Cancer

Florida mother had a complete response to dendritic cell vaccines prior to surgery

From Finish Lines to Infusion Chairs: One Athlete's Journey Through Rare Cancer

After a mantle cell lymphoma diagnosis, Jose Beltran sought a second opinion and found a new path through an immunotherapy clinical trial

Study Explores Immunotherapy Combination for Metastatic Cervical Cancer

Moffitt researchers found that combining radiation and immunotherapy may benefit patients with advanced disease

New Endowed Chair To Advance Cancer Care and Research at Moffitt

The investment will provide long-term support to recruit, expand services and accelerate AI innovation